0001209191-19-022659.txt : 20190402 0001209191-19-022659.hdr.sgml : 20190402 20190402171942 ACCESSION NUMBER: 0001209191-19-022659 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190401 FILED AS OF DATE: 20190402 DATE AS OF CHANGE: 20190402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YAO TONY DUNG LING CENTRAL INDEX KEY: 0001771680 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38841 FILM NUMBER: 19726334 MAIL ADDRESS: STREET 1: C/O PRECISION BIOSCIENCES, INC. STREET 2: 302 EAST PETTIGREW STREET, SUITE A-100 CITY: DURHAM STATE: NC ZIP: 27701 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PRECISION BIOSCIENCES INC CENTRAL INDEX KEY: 0001357874 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 302 EAST PETTIGREW STREET STREET 2: SUITE A-100 CITY: DURHAM STATE: NC ZIP: 27701 BUSINESS PHONE: 919-314-5512 MAIL ADDRESS: STREET 1: 302 EAST PETTIGREW STREET STREET 2: SUITE A-100 CITY: DURHAM STATE: NC ZIP: 27701 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-04-01 0 0001357874 PRECISION BIOSCIENCES INC DTIL 0001771680 YAO TONY DUNG LING C/O PRECISION BIOSCIENCES, INC. 302 E. PETTIGREW STREET, SUITE A-100 DURHAM NC 27701 1 0 0 0 Common Stock 2019-04-01 4 C 0 4450 A 4450 D Common Stock 2019-04-01 4 C 0 36946 13.60 A 36946 I By ArrowMark Life Science Fund, LP Common Stock 2019-04-01 4 C 0 114570 A 151516 I By ArrowMark Life Science Fund, LP Common Stock 2019-04-01 4 C 0 4450 A 4450 I By THB Iron Rose, LLC Life Science Portfolio Series B Preferred Stock 2019-04-01 4 C 0 9500 D Common Stock 4450 0 D Convertible Promissory Note 13.60 2019-04-01 4 C 0 502466.00 D Common Stock 36946 0 I By ArrowMark Life Science Fund, LP Series B Preferred Stock 2019-04-01 4 C 0 244572 D Common Stock 114570 0 I By ArrowMark Life Science Fund, LP Series B Preferred Stock 2019-04-01 4 C 0 9500 D Common Stock 4450 0 I By THB Iron Rose, LLC Life Science Portfolio The Series B Preferred Stock automatically converted into the common stock of Precision BioSciences, Inc. (the "Issuer") on a 2.134686-to-1 basis (after giving effect to the Issuer's previously completed reverse stock split) upon the closing of the Issuer's initial public offering (the "IPO"). These securities are held of record by the ArrowMark Life Science Fund, LP (the "ArrowMark Fund"). ArrowMark Colorado Holdings LLC ("ArrowMark Colorado") is an investment advisor to the ArrowMark Fund. The reporting person is employed as a portfolio manager for ArrowMark Colorado and has direct voting and dispositive control over the shares held by the ArrowMark Fund. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein. These securities are held of record by the THB Iron Rose, LLC Life Science Portfolio (the "THB Fund"). ArrowMark Colorado is an investment advisor to the THB Fund. The reporting person is employed as a portfolio manager for ArrowMark Colorado and has direct voting and dispositive control over the shares held by the THB Fund. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein. On March 1, 2019, the ArrowMark Fund acquired a convertible promissory note in the principal amount of $500,000 (the "2019 Note") from the Issuer. Effective upon the closing of the IPO on April 1, 2019, the 2019 Note, including accrued interest, converted into 36,946 shares of the Issuer's common stock at a price per share equal to $13.60, which represented 85% of the price per share in the IPO. /s/ Abid Ansari, Attorney-in-Fact for Tony Dung-Ling Yao 2019-04-02